Gunderson Dettmer has advised Tarsus Pharmaceuticals. Tarsus Pharmaceuticals (Nasdaq: TARS) (“Tarsus”) has announced that it has entered into a securities purchase agreement with qualified institutional buyers...
Tarsus Pharmaceuticals Raises $125 Million in Oversubscribed PIPE Financing
Tarsus Pharmaceuticals Signs Agreement to Acquire Alkeus Pharmaceuticals
Gunderson Dettmer has advised Tarsus Pharmaceuticals. Latham & Watkins has advised Alkeus Pharmaceuticals. Tarsus Pharmaceuticals (Nasdaq: TARS) has entered into a definitive agreement to acquire Alkeus...
Contineum Therapeutics Prices $90 Million Upsized Public Equity Offering
Gunderson Dettmer has advised Contineum Therapeutics. Contineum Therapeutics, Inc. (Nasdaq: CTNM) (Contineum) a clinical-stage biopharmaceutical company, has announced the pricing of an upsized underwritten public offering...
Aspen Aerogels’ $98 Million Follow-on Offering
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. advised Aspen Aerogels, Inc. on the offering, and Simpson Thacher & Bartlett advised the joint-book running managers. Aspen...
Genpact’s $400 Million Senior Notes Offering
Cravath, Swaine & Moore advised Genpact Luxembourg S.à r.l. and Genpact USA, Inc. on the offering, and Simpson Thacher & Bartlett advised the underwriters. Genpact USA,...
Ohmium’s $250 Million Series C Fundraise
Skadden and Spice Route Legal served as legal counsel to Ohmium, while Kirkland & Ellis served as legal counsel to TPG. Ohmium International announced the close of...